Cardinal Health, a US healthcare services firm, has added the Protexis Latex Hydrogel surgical gloves to its portfolio and released the Protexis brand name for its range of powder-free surgical gloves.
The new surgical gloves are powder-free, made from natural rubber latex, and feature an exclusive coating that makes them easy to put on and wear. Hydrogel (acrylic hydrogel polymer), a hydrophilic coating, is chemically bonded to the interior of the glove, which enhances lubricity so that the gloves glide on easily – wet or dry – and offer a soft, comfortable fit.
The gloves are translucent yellow in colour, which looks like a second layer of skin and offers a contrast to a coloured underglove when double-gloving.
All of the existing Cardinal Health powder-free brands, including Duraprene, Esteem, Protegrity, and Ultrafree, will all be moved across to a single Protexis brand.
The firm says the new brand offers a simple, straightforward naming architecture that clearly communicates the material from which the gloves are made, as well as any key features.
The Protexis powder-free surgical glove portfolio includes a proprietary glove mould with an independent thumb design that provides more natural hand movement along with an interlocking, beaded cuff design that reduces roll-down. Packaging for the portfolio has been redesigned with a fresh look and standardised. All Protexis surgical gloves will be available in sustainable, half-fold pouches that use less material, generate less waste and help increase storage space.
The roll-out of the Protexis brand kicks off with the launch of these Latex Hydrogel surgical gloves this month.
The remainder of the powder-free portfolio will transition to the Protexis name during 2012.
Cardinal introduces Protexis Latex Hydrogel surgical gloves
Releases Protexis brand and will transition powder-free range to this brand name during 2012
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
Regulatory
Why aseptic processing is critical for microsphere drug manufacturing
As microsphere-based drug delivery systems move from niche innovation to commercial reality, manufacturers face growing pressure to guarantee sterility without compromising product integrity. Aseptic processing has become essential to meeting both regulatory expectations and patient safety requirements